SCHEMBL4921169

SCHEMBL4921169

CCCOc1ccc(Nc2ccc(Cl)cc2N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
EHMT2 Q96KQ7 1/20 0.45
MAPT P10636 8/20 0.45
TSHR P16473 1/20 0.42
HRH3 Q9Y5N1 2/20 0.42
TP53 P04637 2/20 0.42
ALDH1A1 P00352 5/20 0.41
GAA P10253 5/20 0.40
MAPK1 P28482 2/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39
THRB P10828 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
MMP14 P50281 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
UNG P13051 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928330 0.89 MEN1 (0.47) MEN1KMT2AEHMT2MAPTTSHR
SCHEMBL5188930 0.89 MAPT (0.57) MEN1KMT2AEHMT2MAPTTSHR
SCHEMBL4927439 0.84 MAPT (0.46) MEN1KMT2AEHMT2MAPTTSHR
SCHEMBL14280666 0.83 KMT2A (0.47) MEN1KMT2AEHMT2MAPTHRH3
SCHEMBL14463886 0.81 MAPT (0.43) MEN1KMT2AMAPTTSHRTP53
SCHEMBL4928513 0.81 MAPT (0.59) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL11346811 0.80 MAPT (0.47) MEN1KMT2AMAPTTP53ALDH1A1
SCHEMBL4921345 0.80 MAPT (0.43) MEN1KMT2AEHMT2MAPTALDH1A1
SCHEMBL4921551 0.79 UNG (0.45) MEN1KMT2AMAPTTSHRGAA
SCHEMBL11750321 0.78 ALDH1A1 (0.48) MEN1KMT2AMAPTTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 MEN1 4097/4885KMT2A 1963/4885EHMT2 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.